Glide Technologies
Recent Finacing
Equity
Recent Raise
$4M
Glide Technologies develops the Glide SDI® needle-free injector to deliver solid-dose therapeutics and vaccines, with programs for teriparatide, exenatide, octreotide, and anthrax and influenza vaccines.
Highlights
Focus Areas
Public Relations
Software
Recent Investors
Financials
$4M
Total Raised
1
Funding round
4
Investors